HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rene Kizek Selected Research

DNA Adducts

1/2015Cytotoxicity of and DNA adduct formation by ellipticine and its micellar form in human leukemia cells in vitro.
6/2012Analysis of covalent ellipticine- and doxorubicin-derived adducts in DNA of neuroblastoma cells by the ³²P-postlabeling technique.
6/2011Ellipticine cytotoxicity to cancer cell lines - a comparative study.
1/2011Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rene Kizek Research Topics

Disease

53Neoplasms (Cancer)
06/2021 - 11/2008
17Prostatic Neoplasms (Prostate Cancer)
11/2018 - 08/2011
9Neuroblastoma
09/2015 - 01/2010
8Carcinogenesis
04/2015 - 07/2010
7Breast Neoplasms (Breast Cancer)
01/2020 - 07/2010
6Carcinoma (Carcinomatosis)
06/2015 - 12/2011
4Wounds and Injuries (Trauma)
08/2020 - 12/2007
4Cardiovascular Diseases (Cardiovascular Disease)
07/2018 - 12/2012
4Infections
11/2017 - 12/2013
4Human Influenza (Influenza)
10/2015 - 11/2012
4Communicable Diseases (Infectious Diseases)
01/2015 - 12/2012
4Pathologic Processes
01/2014 - 04/2011
3Neoplasm Metastasis (Metastasis)
06/2021 - 04/2015
3Squamous Cell Carcinoma of Head and Neck
09/2016 - 03/2014
3Cardiotoxicity
01/2016 - 10/2013
3Heart Failure
01/2016 - 09/2013
3Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2013 - 01/2006
2Cardiomyopathies (Cardiomyopathy)
01/2018 - 01/2016
2Osteosarcoma (Osteogenic Sarcoma)
06/2015 - 06/2013
2Head and Neck Neoplasms (Head and Neck Cancer)
06/2015 - 04/2015
2Adenocarcinoma
03/2015 - 06/2011
2Leukemia
01/2015 - 06/2011
2Bacterial Infections (Bacterial Infection)
03/2014 - 02/2014
2Neurodegenerative Diseases (Neurodegenerative Disease)
09/2013 - 12/2011
2Alzheimer Disease (Alzheimer's Disease)
08/2013 - 01/2006
2Poisoning
01/2013 - 12/2007
1Autism Spectrum Disorder
11/2020
1Mitochondrial Diseases (Mitochondrial Disease)
11/2020
1Neuroinflammatory Diseases
11/2020
1Brain Diseases (Brain Disorder)
11/2020
1Neurodevelopmental Disorders
11/2020
1Sarcosinemia
11/2018
1Mastitis
10/2017

Drug/Important Bio-Agent (IBA)

19MetallothioneinIBA
10/2018 - 05/2008
17Pharmaceutical PreparationsIBA
06/2021 - 01/2010
12Proteins (Proteins, Gene)FDA Link
10/2018 - 01/2006
12ZincIBA
12/2017 - 04/2011
9Sarcosine (Methylglycine)IBA
11/2018 - 06/2013
9Doxorubicin (Adriamycin)FDA LinkGeneric
10/2018 - 06/2010
9Biomarkers (Surrogate Marker)IBA
12/2015 - 08/2011
8IonsIBA
12/2017 - 12/2011
7DNA (Deoxyribonucleic Acid)IBA
01/2016 - 06/2010
7ellipticineIBA
09/2015 - 06/2010
7AntioxidantsIBA
03/2014 - 11/2008
6Cytostatic AgentsIBA
01/2016 - 01/2010
5PlatinumIBA
01/2016 - 01/2010
5Cisplatin (Platino)FDA LinkGeneric
03/2014 - 01/2010
4Liposomes (Liposome)IBA
02/2016 - 12/2014
4Antineoplastic Agents (Antineoplastics)IBA
06/2015 - 06/2010
4DNA AdductsIBA
01/2015 - 01/2011
4Biological ProductsIBA
12/2012 - 11/2008
3EnzymesIBA
11/2020 - 06/2011
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 02/2014
3AntibodiesIBA
12/2017 - 01/2015
3Amino AcidsFDA Link
05/2016 - 06/2013
3MetalsIBA
01/2016 - 03/2012
3Peptides (Polypeptides)IBA
10/2015 - 07/2010
3Hemagglutinins (Hemagglutinin)IBA
10/2015 - 12/2013
3Histone Deacetylase InhibitorsIBA
06/2014 - 06/2010
3Carboplatin (JM8)FDA LinkGeneric
02/2014 - 01/2010
2Glutathione (Reduced Glutathione)IBA
11/2020 - 03/2012
2Glutamic Acid (Glutamate)FDA Link
11/2020 - 05/2016
2Glutathione Disulfide (GSSG)FDA LinkGeneric
11/2020 - 12/2012
2CopperIBA
01/2020 - 12/2011
2AnthracyclinesIBA
01/2019 - 01/2016
2FullerenesIBA
10/2018 - 01/2018
2Reactive Oxygen Species (Oxygen Radicals)IBA
07/2018 - 12/2012
2SeleniumIBA
10/2017 - 02/2014
2Protein Isoforms (Isoforms)IBA
01/2016 - 01/2016
2Environmental Pollutants (Pollutants, Environmental)IBA
01/2016 - 01/2014
2Histones (Histone)IBA
01/2016 - 06/2014
2Free RadicalsIBA
01/2016 - 03/2012
2RNA (Ribonucleic Acid)IBA
01/2016 - 02/2014
2Carrier Proteins (Binding Protein)IBA
12/2015 - 04/2011
2Adenosine Triphosphatases (ATPase)IBA
09/2015 - 09/2013
2LigandsIBA
06/2015 - 05/2014
2MicroRNAs (MicroRNA)IBA
04/2015 - 12/2012
2Estrogen ReceptorsIBA
02/2015 - 05/2014
2Cytotoxins (Cytolysins)IBA
01/2015 - 09/2013
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2014 - 03/2013
2Nucleic AcidsIBA
09/2013 - 12/2012
2Prion ProteinsIBA
09/2013 - 12/2012
2Sulfhydryl Compounds (Thiols)IBA
06/2012 - 07/2010
1NF-kappa B (NF-kB)IBA
11/2020
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2020
1Transcription Factors (Transcription Factor)IBA
11/2020
1CytokinesIBA
11/2020
1SilverIBA
08/2020
1HydrogelsIBA
08/2020
1CarbonIBA
02/2019
1Superoxide DismutaseIBA
10/2018
1fullerene C60IBA
10/2018
1ResveratrolIBA
07/2018
1Immunoglobulin G (IgG)IBA
12/2017
1ChitosanIBA
12/2017
1NucleosidesIBA
11/2017

Therapy/Procedure

22Therapeutics
02/2019 - 06/2010
3Quantum Dots (Quantum Dot)
06/2021 - 09/2013
3Drug Therapy (Chemotherapy)
12/2017 - 01/2010
2Lasers (Laser)
11/2015 - 05/2014